Article
Spike-in probe-enhanced single-cell RNA-seq reveals post-infusion transcriptomic remodeling of “prime-and-kill” synNotch-CAR-T cells
2026-03-29
Abstract excerpt
We previously developed synthetic Notch (synNotch)-chimeric antigen receptor (CAR)-T cells to improve the safety and efficacy of CAR-T therapy for glioblastoma. In this system, an anti-EphA2/IL13Rα2-dual-CAR is expressed only upon recognition of tumor- or brain-specific “priming” antigens, EGFRvIII (termed E-SYNC cells) or brevican (B-SYNC), respectively, with E-SYNC currently under phase I clinical evaluation (...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a314c5a5-0ca0-5d44-aca0-411e0386bf0b
- DOI
- 10.64898/2026.03.26.713760
